
A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.
Specialists in adolescent medicine show you how to evaluate your sexually active female patients for PID and manage this common complication of sexually transmitted disease.






